Poster Abstract Abstract

(Adults - Diabetes mellitus), #220515676451

TYPE 1 DIABETES PATIENT FOLLOW-UP IN DIABETES ONE-STOP CLINIC(DOSC) DURING COVID-19 PANDEMIC: SINGLE CENTRE EXPERIENCE IN PAHANG

Nurbadriah binti Jasmiad, Hospital Sultan Haji Ahmad Shah (HoSHAS); See Chee Keong, Hospital Sultan Haji Ahmad Shah (HoSHAS); Muhammad Muizz Shafiq bin Dato' Shamsul Ismail, Hospital Sultan Haji Ahmad Shah (HoSHAS)

Email Address : 

Phone Number :

0104206419

Introduction

Management of type 1 diabetes(T1D) patients in early adulthood is associated with unique challenges. COVID-19 pandemic had significantly impacted the quality of patient follow-up and access to care. This study assessed the characteristics of T1D patients under diabetes one-stop clinic (DOSC) follow up in Hospital Sultan Haji Ahmad Shah (HoSHAS), Temerloh, Pahang and impact of the pandemic on diabetes control.

Methods

In this cross sectional study, all T1D patients under active follow-up were recruited. Data regarding demographics, diabetes control and COVID-19 infection status were reviewed. Further analyses were performed by dividing them into 2 groups according to COVID-19 infection status: covid-19 positive (group 1) and covid-19 negative (group 2).

Results

30 T1D patients [60% female, 63.3% Malay ethnicity, mean age 24.4 (SD7.4) years, median weight 58.35(IQR 10.3) kg, median disease duration 6.0 (IQR 8.0) years, mean duration under DOSC follow-up 4.1(SD 1.6) years] were analysed. 10.0% of patients had incident retinopathy. 26.7% had recent hospitalisation within the past 12 months, majority due to diabetes ketoacidosis. 13.3% had experienced hypoglycaemia within the past 3 months. Mean HbA1c in T1D increased steadily from 2019 to 2020 and 2021 (8.87% vs 8.93% vs 9.35%). 13 T1D patients (46.4%) had COVID-19 infection between 2020 and 2022. Patients with COVID-19 infections had lower HbA1c than those not infected but it was not statistical significant (8.74% vs 9.07%, p=0.82). They also tended to have more microvascular complications.

Conclusion

COVID-19 pandemic had negatively impacted diabetes control in our cohort. There was also high hospitalisation rate during this period. Patient’s HbA1c level was not associated with increased risk of COVID-19 infection in our cohort.

Abstract Report Header copy.png
Abstract Report Footer copy.png